Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

First commercial service to predict multiple sources of DNA damage
February 2017
SHARING OPTIONS:

MilliporeSigma
 
MilliporeSigma has introduced CAN MultiFlow screening services to more accurately predict genotoxic and mode of action properties of substances, ingredients and drug compounds. Offered through its BioReliance testing facilities, MilliporeSigma will be the first company to provide this service in the United States.
 
The screening process uses flow cytometry to quickly and efficiently screen for clastogens, aneugens and non-genotoxicants (CAN) in pharmaceutical compounds, agricultural chemicals, flavors, fragrances and consumer products. The results from the assay can help manufacturers reject harmful substances during product development or reduce undesirable properties at an early stage.
 
MilliporeSigma

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.